Joseph L. Goldstein, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 30,028 shares at $546.01 ($16.5M) on 2020-09-21, disclosed to the SEC on 2020-09-23.
Open-market sale of $16.5M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $543.19 | 300 | $163K | 1.0% |
| 2 | $543.19 | 300 | $163K | 1.0% |
| 3 | $544.96 | 700 | $381K | 2.3% |
| 4 | $546.01 | 800 | $437K | 2.6% |
| 5 | $547.28 | 1,356 | $742K | 4.5% |
| 6 | $547.28 | 1,356 |
| $742K |
| 4.5% |
| 7 | $548.13 | 3,654 | $2.0M | 12.1% |
| 8 | $548.13 | 3,654 | $2.0M | 12.1% |
| 9 | $549.07 | 2,600 | $1.4M | 8.6% |
| 10 | $549.07 | 2,600 | $1.4M | 8.6% |
| 11 | $550.11 | 1,600 | $880K | 5.3% |
| 12 | $551.09 | 1,501 | $827K | 5.0% |
| 13 | $551.09 | 1,501 | $827K | 5.0% |
| 14 | $552.01 | 513 | $283K | 1.7% |
| 15 | $552.01 | 513 | $283K | 1.7% |
| 16 | $553.17 | 1,101 | $609K | 3.7% |
| 17 | $553.17 | 1,101 | $609K | 3.7% |
| 18 | $554.82 | 899 | $499K | 3.0% |
| 19 | $554.82 | 899 | $499K | 3.0% |
| 20 | $555.74 | 1,530 | $850K | 5.1% |
| 21 | $555.74 | 1,530 | $850K | 5.1% |
| 22 | $552.36 | 20 | $11K | 0.1% |
| Total | $550.07 avg | 30,028 | $16.5M | 100% |
| Filing → |
| REGN | SELL | 2022-04-01 | $1.7M | — | Filing → |
| REGN | SELL | 2021-09-13 | $1.6M | — | Filing → |
| REGN | SELL | 2021-06-08 | $1.0M | — | Filing → |